Multiple genome wide association studies (GWAS) have identified single nucleotide polymorphisms (SNPs) in CD33 that are associated with a change in the risk for Alzheimer’s disease or late onset dementia [6–9]. This evidence concerns the gene CD33 and Alzheimer disease.